Johnson & Johnson Prevails in Talc Ovarian Cancer Lawsuit as Los Angeles Jury Finds No Negligence
Key Insights
A Los Angeles jury sided with Johnson & Johnson, finding the company was not negligent in a lawsuit alleging its talc products caused ovarian cancer (search) in three women.
The verdict represents a significant legal victory for J&J, though the company continues to face thousands of similar lawsuits across the United States.
In a separate ongoing Florida trial, attorneys are debating whether asbestos in J&J's Baby Powder caused the ovarian cancer (search) death of a retired anesthesiologist.
A Los Angeles jury delivered a favorable verdict for Johnson & Johnson on Friday, determining the pharmaceutical giant was not negligent in a lawsuit brought by the families of three women who alleged the company's cosmetic talc products caused their ovarian cancer (search).
The ruling marks a notable legal victory for J&J in the sprawling talc litigation landscape. After careful deliberation, the jury concluded that Johnson & Johnson bore no responsibility in this particular instance, relieving the company of liability in a case that represents just one of many similar claims filed across the country.
The plaintiffs had accused the company of negligence in the sale of its cosmetic talc products, arguing that J&J failed to adequately warn consumers about potential cancer risks associated with long-term talc use.
Ongoing Litigation in Florida
The California verdict arrives as a separate high-profile talc trial unfolds in Miami, Florida. In Sugarman v. Johnson & Johnson, attorneys presented opening statements Monday in a case concerning Marilyn Seskin, a 69-year-old retired anesthesiologist who died of ovarian cancer (search) in 2019.
Seskin's husband, Robert Sugarman, claims that asbestos present in Johnson & Johnson's Baby Powder—which Seskin used for decades—caused her fatal disease. Michael Pendell of Motley Rice (search), representing Sugarman, told jurors that evidence would demonstrate J&J knew its talc products contained asbestos and was aware of associated dangers for decades, yet failed to warn the public.
"If Johnson & Johnson had told the truth about its Baby Powder, that it contained asbestos and caused cancer, this didn't have to happen," Pendell said during his opening statement.
Pendell further alleged that despite scientific evidence linking talc to cancer, the company engaged in a campaign to deny and discredit those findings.
J&J's Defense Strategy
In response, J&J maintains its talc products are safe and contends that Seskin's cancer stemmed from other causes. Kim Bueno of Kirkland & Ellis (search), representing the company, argued that documents indicating talc contained tremolite—a mineral occurring in both asbestos and non-asbestos forms—did not establish the presence of tremolite asbestos specifically.
Bueno emphasized that the most reliable scientific studies on the issue showed no link between talc and ovarian cancer (search). She also noted that none of Seskin's medical treatment records indicated talc as the cause of her disease.
"Ms. Seskin's cancer wasn't caused by Johnson's Baby Powder," Bueno stated. "No causation, no case."
The Florida proceeding comes two years after an earlier trial in the same case resulted in a deadlocked jury. The current trial is expected to last through the end of next week.
Broader Litigation Context
The cases are part of thousands of claims nationwide alleging that J&J's talc products caused diseases including mesothelioma (search) and ovarian cancer (search). The company pulled its talc-based products from the U.S. and Canadian markets in 2020 and completed the worldwide removal of talcum powder from its products in 2023.